Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
418 Leser
Artikel bewerten:
(2)

Derwent Investments Pte Ltd: Derwent Investments AI Start-up Revenue Generation Superior to Earlier Software Companies

Finanznachrichten News

SINGAPORE, SINGAPORE / ACCESSWIRE / October 7, 2024 / Investment management concern, Derwent Investments today emphasised the accelerated growth trajectory of artificial intelligence (AI) start-ups, pointing to their ability to generate revenue at a faster pace than previous waves of software companies. This trend, it believes, highlights the transformative impact AI is having across industries and the significant opportunities it presents for investors.

Bigger revenues in less time

In a research note sent to clients last week, the firm's analysts drew attention to the contrast between earlier generations of software companies that typically required years to reach profitability and today's AI-driven start-ups which are achieving substantial revenues in a fraction of the time.

These companies, leveraging breakthroughs in machine learning, natural language processing, and automation, are rapidly integrating their solutions into a wide array of industries, from healthcare and finance to logistics and retail.

Burgeoning demand for AI solutions

Derwent Investments ' Edward Chandler, Director of Private Equity, noted: "The rise of AI start-ups marks a notable shift in how quickly technology can impact markets and generate financial returns. Many of these companies are tapping into immediate demand for AI solutions, allowing them to monetise their products and services much earlier in their growth cycle. This dynamic is a real game-changer for both founders and investors alike."

Among the factors contributing to the swift revenue generation of AI start-ups is direct market demand where AI solutions are addressing pressing business needs, such as data analytics, automation of processes, and personalised customer experiences, which accelerates adoption and scaling.

Another aspect impacting fast revenue generation is the so-called pre-built ecosystems. Unlike earlier software firms that had to build infrastructure from scratch, AI start-ups are benefitting from cloud computing platforms and open-source AI tools, reducing development time and costs.

Investment opportunities in AI

The rapid commercialisation of AI is creating unprecedented investment opportunities. As AI continues to disrupt traditional industries and create new markets, companies that are positioned to scale quickly will drive significant returns for early-stage investors. Derwent Investments actively identifies and invests in AI start-ups that demonstrate the potential for high revenue growth and long-term impact.

"AI start-ups are not just an emerging trend; they represent the future of technology-driven innovation," added Mr. Chandler. "For investors, understanding the dynamics of this space and acting quickly is key to capturing the value these companies are poised to deliver."

About Derwent Investments :

Derwent Investments is a leading investment management firm committed to delivering superior investment results and second-to-none client service. With a team of experienced professionals and a disciplined, research-led approach to investing, the firm provides innovative solutions and opportunities for medium-to-long-term capital growth. Derwent Investments' focus on research-driven investment strategies ensures clients benefit from the latest market insights and technological advancements.

Media Contact Details:-

Organization: Derwent Investments Pte Ltd
Website: https://derwentinv.com/
Email: media@derwentinv.com

SOURCE: Derwent Investments Pte Ltd



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.